Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease‐Related Dementia
Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M P Singh, Manchala Raghunath · 2025
Read Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease‐Related Dementia by Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M P Singh, Manchala Raghunath (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712378.txt.
Description
Psychedelic drugs as a path to treat Alzheimer dementia are reviewed by Jitendra Kumar Sinha and co-authors in work dated 2025. Such drugs were long tied to rite and leisure use. They act on a serotonin switch and can boost brain wiring growth through two signal webs. Their role in brain-wasting disease has stayed near untouched till now.
Fresh work shows three named drugs ease signal faults tied to Alzheimer disease. Paths in view span a growth factor chain, a cell growth switch, and cell self-cleaning. Dose sets the line between help and harm. Long-term safety proof is still owed, the team stresses.
Catalog record
| CREATOR | Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M P Singh, Manchala Raghunath |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |